Nora Tommi, Heinonen Hanna, Tenhunen Mirja, Rainesalo Sirpa, Järvenpää Soila, Lehtimäki Kai, Peltola Jukka
Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
Department of Clinical Neurophysiology, Medical Imaging Centre and Hospital Pharmacy, Pirkanmaa Hospital District, Tampere, Finland.
Front Neurol. 2018 Feb 19;9:66. doi: 10.3389/fneur.2018.00066. eCollection 2018.
Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is a method of neuromodulation used for refractory focal epilepsy. We report a patient suffering from drug-resistant epilepsy who developed novel visual symptoms and atypical seizures with the onset of ANT-DBS therapy. Rechallenge under video electroencephalography recording confirmed that lowering the stimulation voltage alleviated these symptoms. Subsequent stimulation with the initial voltage value did not cause the recurrence of either the visual symptoms or the new seizure type, and appeared to alleviate the patient's seizures in long-term follow-up. We therefore hypothesize that the occurrence of stimulation induced seizures at the onset of DBS therapy should not be considered as a failure in the DBS therapy, and the possibility of a subsequent favorable response to the treatment still exists.
丘脑前核(ANT)的深部脑刺激(DBS)是一种用于难治性局灶性癫痫的神经调节方法。我们报告了一名患有耐药性癫痫的患者,在接受ANT-DBS治疗后出现了新的视觉症状和非典型发作。在视频脑电图记录下重新刺激证实,降低刺激电压可缓解这些症状。随后以初始电压值进行刺激并未导致视觉症状或新发作类型的复发,并且在长期随访中似乎减轻了患者的癫痫发作。因此,我们推测在DBS治疗开始时出现的刺激诱发癫痫不应被视为DBS治疗失败,后续仍有可能对治疗产生良好反应。